Dawnrays Pharmaceutical Reports HY Net Income Attributable Of RMB104.6 MLN
RefinitivMeno di 1 minuto di lettura
Dawnrays Pharmaceutical (Holdings) Ltd 2348:
DECLARED INTERIM DIVIDEND OF HK$0.015 PER SHARE
DAWNRAYS PHARMACEUTICAL (HOLDINGS) H1 REVENUE RMB 630.4 MILLION
DAWNRAYS PHARMACEUTICAL (HOLDINGS) H1 NET INCOME ATTRIBUTABLE RMB 104.6 MILLION
Accedi o crea un account gratuito per leggere queste notizie